Literature DB >> 23998980

Complications of gastro-oesophageal reflux disease.

S Parasa1, P Sharma.   

Abstract

Gastro-oesophageal reflux disease (GORD) is on the rise with more than 20% of the western population reporting symptoms and is the most common gastrointestinal disorder in the United States. This increase in GORD is not exactly clear but has been attributed to the increasing prevalence of obesity, changing diet, and perhaps the decreasing prevalence of H. pylori infection. Complications of GORD could be either benign or malignant. Benign complications include erosive oesophagitis, bleeding and peptic strictures. Premalignant and malignant lesions include Barrett's metaplasia, and oesophageal cancer. Management of both the benign and malignant complications can be challenging. With the use of proton-pump inhibitors, peptic strictures (i.e., strictures related to reflux) have significantly declined. Several aspects of Barrett's management remain controversial including the stage in the disease process which needs to be intervened, type of the intervention and surveillance of these lesions to prevent development of high grade dysplasia and oesophageal adenocarcinoma.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Barrett's oesophagitis; Erosive oesophagitis; Gastro-oesophageal reflux disease; Strictures

Mesh:

Year:  2013        PMID: 23998980     DOI: 10.1016/j.bpg.2013.07.002

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  7 in total

1.  Common GI Drug Interactions in the Elderly.

Authors:  Marina Kim; Aamir Dam; Jesse Green
Journal:  Curr Treat Options Gastroenterol       Date:  2014-09

2.  Cardiac autonomic dysfunction in patients with gastroesophageal reflux disease.

Authors:  Branislav Milovanovic; Branka Filipovic; Slavica Mutavdzin; Marija Zdravkovic; Tatjana Gligorijevic; Jovana Paunovic; Marina Arsic
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

3.  Gastroesophageal reflux symptoms do not correlate with objective pH testing after peroral endoscopic myotomy.

Authors:  Edward L Jones; Michael P Meara; Jennifer S Schwartz; Jeffrey W Hazey; Kyle A Perry
Journal:  Surg Endosc       Date:  2015-06-27       Impact factor: 4.584

4.  Gender differences in the association of non-alcoholic fatty liver disease and metabolic syndrome with erosive oesophagitis: a cross-sectional study in a Taiwanese population.

Authors:  Wei-Chieh Hung; Jin-Shang Wu; Zih-Jie Sun; Feng-Hwa Lu; Yi-Ching Yang; Chih-Jen Chang
Journal:  BMJ Open       Date:  2016-11-15       Impact factor: 2.692

5.  Biodegradable esophageal stents in benign and malignant strictures - a single center experience.

Authors:  Dimitrios E Sigounas; Sandeep Siddhi; John N Plevris
Journal:  Endosc Int Open       Date:  2016-04-15

6.  Prevalence, associated factors and medication for symptoms related to gastroesophageal reflux disease among 1114 private-tuition students of Anuradhapura, Sri Lanka.

Authors:  Darsha Gunasinghe; Chathurika Gunawardhana; Shakthi Halahakoon; Ali Haneeka; Najiyya Hanim; Chamara Hapuarachchi; Devarajan Rathish
Journal:  BMC Gastroenterol       Date:  2020-02-27       Impact factor: 3.067

7.  Gastroesophageal reflux disease and its related factors among women of reproductive age: Korea Nurses' Health Study.

Authors:  Oksoo Kim; Hee Jung Jang; Sue Kim; Hea-Young Lee; Eunyoung Cho; Jung Eun Lee; Heeja Jung; Jiyoung Kim
Journal:  BMC Public Health       Date:  2018-09-21       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.